These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7537539)
21. [Leucine zippers improves protein splicing-mediated coagulation factor VIII gene delivery by dual-vector system]. Zhu FX; Yang SD; Liu ZL; Miao J; Qu HG; Chi XY Yao Xue Xue Bao; 2012 Jan; 47(1):39-44. PubMed ID: 22493803 [TBL] [Abstract][Full Text] [Related]
22. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene. Ishiwata A; Mimuro J; Kashiwakura Y; Niimura M; Takano K; Ohmori T; Madoiwa S; Mizukami H; Okada T; Naka H; Yoshioka A; Ozawa K; Sakata Y Thromb Res; 2006; 118(5):627-35. PubMed ID: 16371232 [TBL] [Abstract][Full Text] [Related]
23. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero. Lipshutz GS; Sarkar R; Flebbe-Rehwaldt L; Kazazian H; Gaensler KM Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13324-9. PubMed ID: 10557319 [TBL] [Abstract][Full Text] [Related]
24. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII]. Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):457-9. PubMed ID: 11877017 [TBL] [Abstract][Full Text] [Related]
25. Partial correction of murine hemophilia A with neo-antigenic murine factor VIII. Sarkar R; Gao GP; Chirmule N; Tazelaar J; Kazazian HH Hum Gene Ther; 2000 Apr; 11(6):881-94. PubMed ID: 10779165 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow stromal cells as targets for gene therapy of hemophilia A. Chuah MK; Brems H; Vanslembrouck V; Collen D; VandenDriessche T Hum Gene Ther; 1998 Feb; 9(3):353-65. PubMed ID: 9508053 [TBL] [Abstract][Full Text] [Related]
27. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy. Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084 [TBL] [Abstract][Full Text] [Related]
28. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction. Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221 [TBL] [Abstract][Full Text] [Related]
29. Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A. Brown BD; Shi CX; Powell S; Hurlbut D; Graham FL; Lillicrap D Blood; 2004 Feb; 103(3):804-10. PubMed ID: 14512318 [TBL] [Abstract][Full Text] [Related]
30. Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Connelly S; Andrews JL; Gallo AM; Kayda DB; Qian J; Hoyer L; Kadan MJ; Gorziglia MI; Trapnell BC; McClelland A; Kaleko M Blood; 1998 May; 91(9):3273-81. PubMed ID: 9558383 [TBL] [Abstract][Full Text] [Related]
31. Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats. Van Damme A; Chuah MK; Dell'accio F; De Bari C; Luyten F; Collen D; VandenDriessche T Haemophilia; 2003 Jan; 9(1):94-103. PubMed ID: 12558785 [TBL] [Abstract][Full Text] [Related]
32. Sustained expression of Epstein-Barr virus episomal vector mediated factor VIII in vivo following muscle electroporation. Mei WH; Qian GX; Zhang XQ; Zhang P; Lu J Haemophilia; 2006 May; 12(3):271-9. PubMed ID: 16643213 [TBL] [Abstract][Full Text] [Related]
33. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Chao H; Mao L; Bruce AT; Walsh CE Blood; 2000 Mar; 95(5):1594-9. PubMed ID: 10688813 [TBL] [Abstract][Full Text] [Related]
34. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon. Liu L; Mah C; Fletcher BS Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640 [TBL] [Abstract][Full Text] [Related]
36. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice. Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Takano K; Ohmori T; Madoiwa S; Ozawa K; Sakata Y J Gene Med; 2009 Nov; 11(11):1020-9. PubMed ID: 19757487 [TBL] [Abstract][Full Text] [Related]
37. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. Kang Y; Xie L; Tran DT; Stein CS; Hickey M; Davidson BL; McCray PB Blood; 2005 Sep; 106(5):1552-8. PubMed ID: 15886327 [TBL] [Abstract][Full Text] [Related]
38. Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation. Koeberl DD; Halbert CL; Krumm A; Miller AD Hum Gene Ther; 1995 Apr; 6(4):469-79. PubMed ID: 7542032 [TBL] [Abstract][Full Text] [Related]
39. [Human factor VIII expression in retrovirus vector-transduced bone marrow stromal cells]. Guo X; Wang H; Chu H Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):461-3. PubMed ID: 11758224 [TBL] [Abstract][Full Text] [Related]
40. Inter-chain disulfide bond improved protein trans-splicing increases plasma coagulation activity in C57BL/6 mice following portal vein FVIII gene delivery by dual vectors. Zhu F; Liu Z; Wang X; Miao J; Qu H; Chi X Sci China Life Sci; 2013 Mar; 56(3):262-7. PubMed ID: 23526393 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]